What type of study is this?

This is a Literature Review study (also classified as: Quantitative Study).

September 20, 2025

Is there a role for metabolic imaging in pediatric non-Hodgkin lymphoma?

View Full Paper

Ask AI

Bookmark

Authors

This review assesses the role of [18F]FDG PET/CT in pediatric non-Hodgkin lymphoma, highlighting its diagnostic and prognostic implications.

[18F]FDG PET/CT significantly improves staging accuracy in pediatric non-Hodgkin lymphoma by detecting extranodal involvement.
It confirms complete metabolic response with a high negative predictive value, reducing unnecessary biopsies.
Novel biomarkers like metabolic tumor volume and total lesion glycolysis show potential but face standardization challenges.
Ongoing trials are essential to validate and standardize [18F]FDG PET/CT applications in clinical settings.

Guerra et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This review assesses the role of [18F]FDG PET/CT in pediatric non-Hodgkin lymphoma, highlighting its diagnostic and prognostic implications.